Cheap Tools. Expensive Judgment.

Dhruv Wadhwa

·

An MIT researcher made an observation I can't shake: when the cost of doing something collapses by 1,000x, any organization that doesn't adopt the technology faces an existential disadvantage.

Cheap tools. Expensive judgment. That's the new dividing line.

The software that cost your marketing department six figures five years ago now costs less than your team's coffee budget. Email platforms, CRM tools, AI-assisted content, audience targeting — all available to everyone, at almost no cost.

That should excite you. It should also terrify you.

Because if everyone has access to the same tools at the same price, the tools aren't your advantage. They're table stakes. Software will hand you an email list for the same price it hands one to your competitor.

The question is no longer whether you can reach your buyer. It's what happens when everyone else can too.

What eCommerce Taught Me About B2B

In 2024, I started an eCommerce company. No playbook. I failed early and often. But I noticed something: the market didn't punish bad attempts, it just ignored them. What it rewarded was showing up again.

By 2025 I was collecting 500 emails a week at 30 cents each. Two years earlier, getting a comparable name meant flying to a conference with a minimum booth cost of $2,500 to $10,000.

But the emails themselves weren't what mattered. The addresses were easy to get, and so was the content to send them.

What actually moved the needle was getting people to come back. Every return visit raised the odds of a sale. The jump from one visit to two did more for conversion than anything else I tried.

Give Before You Ask

Cialdini's principle of reciprocity: people return value to those who gave it to them first.

In eCommerce, that meant a sizing guide, a comparison post, something useful before the ask. In B2B, it's the same instinct wearing different clothes — a whitepaper instead of a sizing guide, a post that actually entertains or educates instead of a comparison chart. The format changes. The math doesn't: give first, and people come back believing time with you is worth spending. Lead with the ask, and you get silence.

In clinical trials, the psychology is identical, just harder. Instead of one buyer, you're aligning 8 to 10 stakeholders, most of whom are forming opinions months before an RFP ever goes out. It happens in private conversations, peer recommendations, LinkedIn feeds, conference hallways. Or worse, nowhere you can see at all. That's the dark funnel.

The rep who shows up in those moments with a perspective, not a pitch, is the one giving before asking. That's how you earn the return visit in B2B.

From One Visit to Two, Then Two to Three.

Four out of five B2B deals are won by the buyer's pre-contact favorite. 83% of the buying process happens without you in the room.

Which of your accounts are currently forming an opinion of you without you knowing it?


If the answer is "I don't know," that's not a technology problem. It's a visibility problem. Tools that unmask which companies are quietly showing up on your website have never been cheaper or easier to run. But they only have something to reveal if there's a signal to catch — which is exactly why showing up publicly, the way this post is trying to, matters more than it looks like it should. What's expensive isn't the tool. It's the judgment to use what it shows you.

P.S. Up next in Article 3: the best solution doesn't always win. An NFL story explains why and it has everything to do with your next pitch.


Sources:

Image 2: HockeyStack Labs 2024; Sellers Commerce; Kondo/Forrester; EmailToolTester 2025)